Adam McCluskey

(BScHons and PhD) graduate in chemistry of the University of Strathclyde, Scotland.

Joined University of Newcastle in 1995 and resides in the School of Environmental and Life Sciences.

Professor McCluskey’s primary areas of research are medicinal chemistry and chemical biology developing tools and drugs targeting endocytosis. He leads the Dynamin Modulators platform which supplies the only known endocytosis inhibitors to research teams worldwide. He heads the chemistry component of the Australian Cancer Research Foundation Centre for Kinomics (CFK) at the University of Newcastle where he makes extensive use of flow chemistry.